Sentinel Lymph Node Biopsy in Thyroid Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The role of sentinel lymph node biopsy (SLNB) in thyroid cancer is still debatable. The primary goals of SLNB are to facilitate accurate identification of lymph node (LN) metastasis without formal lymphadenoectomy to reduce morbidity associated with LN dissection. SLN in thyroid cancer can be identified using either vital blue dye, radioactive tracer, or a combination of these methods. Here, 26 selected studies of SLNB for thyroid cancer are analyzed and reviewed. For the vital blue dye, radioisotope, and combined methods, the overall sentinel node identification rates (SNIRs) were 84.0, 98.4 and 97.9%, the overall sensitivities were 86.1, 66.7 and 90.7% and the overall false negative rates were 11.4, 16.3, and 11.4%, respectively. The combined blue dye and radioisotope method had superior SNIRs, sensitivities, and false negative rates than the single vital blue dye technique. New tracers such as carbon nanoparticles can be used in SLNB. Lateral compartment SLNB studies employing a radioisotope technique can be useful for evaluation of the occult lateral neck LN status in patients with papillary thyroid cancer (PTC), especially in cases of central neck node metastasis. Lateral SLNB may also provide useful information for medullary thyroid cancer (MTC) treatment.
Abstract
The role of sentinel lymph node biopsy (SLNB) in thyroid cancer is still debatable. The primary goals of SLNB are to facilitate accurate identification of lymph node (LN) metastasis without formal lymphadenoectomy to reduce morbidity associated with LN dissection. SLN in thyroid cancer can be identified using either vital blue dye, radioactive tracer, or a combination of these methods. Here, 26 selected studies of SLNB for thyroid cancer are analyzed and reviewed. For the vital blue dye, radioisotope, and combined methods, the overall sentinel node identification rates (SNIRs) were 84.0, 98.4 and 97.9%, the overall sensitivities were 86.1, 66.7 and 90.7% and the overall false negative rates were 11.4, 16.3, and 11.4%, respectively. The combined blue dye and radioisotope method had superior SNIRs, sensitivities, and false negative rates than the single vital blue dye technique. New tracers such as carbon nanoparticles can be used in SLNB. Lateral compartment SLNB studies employing a radioisotope technique can be useful for evaluation of the occult lateral neck LN status in patients with papillary thyroid cancer (PTC), especially in cases of central neck node metastasis. Lateral SLNB may also provide useful information for medullary thyroid cancer (MTC) treatment.
참고문헌 (36)
- Roh JL, "Role of sentinel lymph node biopsy in thyroid cancer", Expert Rev Anticancer Ther, 10, pp.1429~1437 (2010)
- Kelemen PR, "Sentinel lymphadenectomy in thyroid malignant neoplasms", Arch Surg, 133, pp.288~292 (1998)
- Balasubramanian SP, "Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer", Br J Surg, 98, pp.334~344 (2011)
- Wada N, "Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection", Ann Surg, 237, pp.399~407 (2003)
- Randolph GW, "The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension", Thyroid, 22, pp.1144~1152 (2012)
- Zeiger MA, "Evolution in the surgical management of well-differentiated thyroid cancer or not: to dissect or not dissect the central lymph node compartment", J Surg Oncol, 101, pp.101~102 (2010)
- Montgomery LL, "Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer", Anesth Analg, 95, pp.385~388 (2002)
- Takeyama H, "Sentinel node biopsy for follicular tumours of the thyroid gland", Br J Surg, 96, pp.490~495 (2009)
- Lee SK, "Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer", Eur J Surg Oncol, 35, pp.974~979 (2009)
- Stoeckli SJ, "Sentinel lymph node biopsy in thyroid tumors: a pilot study", Eur Arch Otorhinolaryngol, 260, pp.364~368 (2003)
- Catarci M, "Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer", A pilot study. J Surg Oncol, 77, pp.21~24 (2001)
- Boschin IM, "99Tc Nanocolloid sentinel node procedure in thyroid carcinoma", Langenbecks Arch Surg, 393, pp.705~708 (2008)
- Amir A, "Sentinel lymph node biopsy in thyroid cancer: it can work but there are pitfalls", Otolaryngol Head Neck Surg, 145, pp.723~726 (2011)
- Hao RT, "Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma", Eur J Surg Oncol, 38, pp.718~724 (2012)
- Dixon E, "Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms", World J Surg, 24, pp.1396~1401 (2000)
- Takami H, "Detection of sentinel lymph nodes in patients with papillary thyroid cancer", Asian J Surg, 26, pp.145~148 (2003)
- Cunningham DK, "Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institution", Ann Surg Oncol, 17, pp.2970~2975 (2010)
- Fukui Y, "Sentinel lymph node biopsy in patients with papillary thyroid carcinoma", Cancer, 92, pp.2868~2874 (2001)
- Dzodic R, "Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma", World J Surg, 30, pp.841~846 (2006)
- Falvo L, "De Stefano M, Vanni B, et al. The sentinel lymph node in papillary cancer of the thyroid including histological subtype", Ann Ital Chir, 77, pp.13~18 (2006)
- "Rev Laryngol Otol Rhinol (Bord)", 2008, 285~287
- Roh JL, "Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma", Cancer, 113, pp.1527~1531 (2008)
- Bae JS, "Endoscopic thyroidectomy and sentinel lymph node biopsy via an anterior chest approach for papillary thyroid cancer", Surg Today, 39, pp.178~181 (2009)
- Anand SM, "The role of sentinel lymph node biopsy in differentiated thyroid carcinoma", Arch Otolaryngol Head Neck Surg, 135, pp.1199~1204 (2009)
- Tsugawa K, "Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland", Biomed Pharmacother, 56(Suppl 1), pp.100s~103s (2002)
- Chow TL, "Sentinel lymph node dissection in papillary thyroid carcinoma", ANZ J Surg, 74, pp.10~12 (2004)
- Peparini N, "Campana EP. Blue-dye sentinel node mapping in thyroid carcinoma: debatable results of feasibility", Acta Chir Belg, 106, pp.523~527 (2006)
- Rubello D, "Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method?", J Exp Clin Cancer Res, 25, pp.483~486 (2006)
- Rettenbacher L, "Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma", Eur J Nucl Med, 27, pp.1399~1401 (2000)
- Huang O, "Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma", BMC Cancer, 11, pp.386~ (2011)
- Lee SK, "The efficacy of lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma", World J Surg, 35, pp.2675~2682 (2011)
- Doherty GM, "Sentinel lymph node biopsy for papillary thyroid cancer: commentary on the efficacy of lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma by Se Kyung Lee et al", World J Surg, 35, pp.2683~ (2011)
- American Thyroid Association Guidelines Task Force, "Medullary thyroid cancer: management guidelines of the American Thyroid Association", Thyroid, 19, pp.565~612 (2009)
- Arch-Ferrer J, "Accuracy of sentinel lymph node in papillary thyroid carcinoma", Surgery, 130, pp.907~913 (2001)
- Ji YB, "Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma", Ann Surg Oncol, 19, pp.1868~1873 (2012)
- Carcoforo P, "Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma", Eur J Surg Oncol, 33, pp.1075~1080 (2007)